User:Hafsa Ghaffar: Difference between revisions
Jump to navigation
Jump to search
| Line 49: | Line 49: | ||
* '''Clinical Trial''' | * '''Clinical Trial''' | ||
*Comparison of Immunity Following Inactivated Poliovirus Vaccine Versus Fractional Dose Inactivated Poliovirus Vaccine: a Community Based Randomized Controlled Trial in Pakistan. | * *Comparison of Immunity Following Inactivated Poliovirus Vaccine Versus Fractional Dose Inactivated Poliovirus Vaccine: a Community Based Randomized Controlled Trial in Pakistan. | ||
Revision as of 04:58, 17 July 2021
Hafsa Ghaffar, M.D
Contact:
Email: [1]
Medical Education
- 2009 – 2015
- Baqai Medical University.
Certifications
- Registered general practitioner, Pakistan Medical Commission(PMC), Pakistan.
- Educational Commission for Foreign Medical Graduates (ECFMG) certified: October 2020.
Clinical Experience
- April 2021 - Peresent
- Volunteering as a Wiki doc scholar.
- May 2018 – January 2019
- Working as a medical officer in Paediatrics Oncology, The Indus Hosptial, Karachi, Pakistan.
- March 2015- February 2016
- Internship program,Jinnah Post Medical Centre, Karachi, Pakistan.
- June 2021-Current
- Research Associate Department Of Pediatrics, Agha Khan University Hospital.
- Supervisor: Dr.Ali Faisal Saleem, Associate Professor Pediatrics and Editor in Chief of the Clinical Trial.
- Working as a Research Associate under the guidance of Dr.Ali Faisal on the clinical trial in collaboration with World Health Organisation and Aga Khan University Hospital.
- Supervisor: Dr.Ali Faisal Saleem, Associate Professor Pediatrics and Editor in Chief of the Clinical Trial.
- Research Associate Department Of Pediatrics, Agha Khan University Hospital.
Membership
- 2010-Present
- Member of the organisation, Unified Liaison For Promotion of Health and Advanced Treatment (ULPHAT), Pakistan.
Communication Languages
- English
- Urdu
Editorial Work
- Chapter
- Clinical Trial
- *Comparison of Immunity Following Inactivated Poliovirus Vaccine Versus Fractional Dose Inactivated Poliovirus Vaccine: a Community Based Randomized Controlled Trial in Pakistan.